“Cerebrospinal Fluid Protein Level and Nerve Conduction Study as Short-Term Prognostic Marker of Guillain Barré Syndrome”, Bangla. J. Neuroscience, vol. 34, no. 2, pp. 79–84, Jul. 2018, doi: 10.3329/bjn.v34i2.57551.